199
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Sonochemical Synthesis and In Silico Evaluation of Imidazo[1,2-a]Pyridine Derivatives as Potential Inhibitors of Sirtuins

, , , , , , & show all
Pages 3741-3760 | Received 28 Feb 2022, Accepted 06 May 2022, Published online: 18 May 2022

References

  • D. Belohlavek, and P. Malfertheiner, “The Effect of Zolimidine, Imidazopyridine-Derivate, on the Duodenal Ulcer Healing,” Scandinavian Journal of Gastroenterology. Supplement 54 (1979): 44.
  • A. N. Jain, “Ligand-Based Structural Hypotheses for Virtual Screening,” Journal of Medicinal Chemistry 47, no. 4 (2004): 947–61. doi:10.1021/jm030520f.
  • H. Depoortere, and P. George, “Imidazopyridine for use as an anaesthetic, US patent application number 5064836, Nov 12, 1991.
  • D. J. Sanger, “Behavioural Effects of Novel Benzodiazepine (!w) Receptor Agonists and Partial Agonists: Increases in Punished Responding and Antagonism of the Pentylenetetrazole Cue,” Behavioural Pharmacology 6 (1995): 116–26.
  • B. Du, A. Shan, Y. Zhang, X. Zhong, D. Chen, and K. Cai, “Zolpidem Arouses Patients in Vegetative State after Brain Injury: Quantitative Evaluation and Indications,” The American Journal of the Medical Sciences 347, no. 3 (2014): 178–82. doi:10.1097/MAJ.0b013e318287c79c.
  • S. M. Park, J. Ryu, D. R. Lee, D. Shin, J. M. Yun, and J. Lee, “Zolpidem Use and Risk of Fractures: A Systematic Review and Meta-Analysis,” Osteoporosis International 27, no. 10 (2016): 2935–44. doi:10.1007/s00198-016-3605-8.
  • Y. S. Tung, M. S. Coumar, Y. S. Wu, H. Y. Shiao, J. Y. Chang, J. P. Liou, P. Shukla, C. W. Chang, C. Y. Chang, C. C. Kuo, et al, “Scaffold-Hopping Strategy: synthesis and Biological Evaluation of 5,6-Fused Bicyclic Heteroaromatics to Identify Orally Bioavailable Anticancer Agents,” Journal of Medicinal Chemistry 54, no. 8 (2011): 3076–80. doi:10.1021/jm101027s.
  • H.-P. Hseih, Y.-S. Chao, J.-P. Liou, J.-Y. Chang, and Y.-S. Tung, “Antitumor Compounds,” US Patent Application No. 7,456,289 B2. Nov. 25, 2008.
  • R. L. Casaubon, R. Narayan, C. Oalmann, and C. B. Vu, “Substituted Bicyclic Azaheterocycles and Analogues as Sirtuin Modulators,” World Patent Application No. WO/2013/059587, 24 April, 2013.
  • S. Michan, and D. Sinclair, “Sirtuins in Mammals: Insights into their Biological Function,” The Biochemical Journal 404, no. 1 (2007): 1–13. doi:10.1042/BJ20070140.
  • T. Liu, P. Y. Liu, and G. M. Marshall, “The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer,” Cancer Research 69, no. 5 (2009): 1702–5. doi:10.1158/0008-5472.CAN-08-3365.
  • A. Ghosh, A. Sengupta, G. P. K. Seerapu, A. Nakhi, E. V. V. S. Ramarao, N. Bung, G. Bulusu, M. Pal, and D. Haldar, “A Novel SIRT1 Inhibitor, 4bb Induces Apoptosis in HCT116 Human Colon Carcinoma Cells Partially by Activating p53,” Biochemical and Biophysical Research Communications 488, no. 3 (2017): 562–9. http://dbtindia.gov.in/sites/default/files/Discovery%20of%20a%20novel%20inhibitor%20of%20HDAC%20SIRT1%20which%20kills%20colon%20cancer%20cells.pdf. doi:10.1016/j.bbrc.2017.05.089.
  • A. Nakhi, S. Archana, G. P. K. Seerapu, K. S. Chennubhotla, K. L. Kumar, P. Kulkarni, D. Haldar, and M. Pal, “AlCl3-Mediated Hydroarylation–Heteroarylation in a Single Pot: A Direct Access to Densely Functionalized Olefins of Pharmacological Interest,” Chemical Communications 49, no. 56 (2013): 6268–70. doi:10.1039/c3cc42840k.
  • C. S. Challa, N. K. Katari, V. Nallanchakravarthula, D. Nayakanti, R. Kapavarapu, and M. Pal, “Sonochemical Synthesis of 2-Substituted Nicotinic Acid Ethyl Ester Derivatives: Their in Vitro and Insilico Evaluation against SIRT1,” Journal of Molecular Structure. 1245 (2021): 131069. doi:10.1016/j.molstruc.2021.131069.
  • C. S. Challa, N. K. Katari, V. Nallanchakravarthula, D. Nayakanti, R. Kapavarapu, and M. Pal, “Amberlyst-15 Catalysed Sonochemical Synthesis of 2-Amino-4,6-Disubstituted Nicotinonitrile Derivatives and Their Biological Evaluation,” Journal of Molecular Structure 1240 (2021): 130541. doi:10.1016/j.molstruc.2021.130541.
  • C. S. Challa, N. K. Katari, V. Nallanchakravarthula, D. Nayakanti, R. Kapavarapu, and M. Pal, “Wang-OSO3H Catalyzed Green Synthesis of 2-Arylamino-3-Cyanopyridine Derivatives under Ultrasound: Their Assessment as Potential Inhibitors of SIRT1,” Journal of Molecular Structure. 1253 (2022): 132309. doi:10.1016/j.molstruc.2021.132309.
  • K. Manjulatha, S. Srinivas, N. Mulakayala, D. Rambabu, M. Prabhakar, K. M. Arunasree, M. Alvala, M. V. Basaveswara Rao, and M. Pal, “Ethylenediamine Diacetate (EDDA) Mediated Synthesis of Aurones under Ultrasound: Their Evaluation as Inhibitors of SIRT1,” Bioorganic & Medicinal Chemistry Letters 22, no. 19 (2012): 6160–5. doi:10.1016/j.bmcl.2012.08.017.
  • L. Hariss, K. B. Hadir, M. El-Masri, T. Roisnel, R. Grée, and A. Hachem, “Preparation of imidazo[1,2-a]-N-heterocyclic Derivatives with Gem-difluorinated Side Chains,” Beilstein Journal of Organic Chemistry 13 (2017): 2115–21. doi:10.3762/bjoc.13.208.
  • K. Pericherla, P. Kaswan, K. Pandey, and A. Kumar, “Recent Developments in the Synthesis of Imidazo[1,2-α]Pyridines,” Synthesis 47, no. 07 (2015): 887–912. doi:10.1055/s-0034-1380182.
  • A. K. Bagdi, S. Santra, K. Monir, and A. Hajra, “Synthesis of Imidazo[1,2-a]Pyridines: A Decade Update,” Chemical Communications (Cambridge, England) 51, no. 9 (2015): 1555–75. doi:10.1039/c4cc08495k.
  • H. Okai, K. Tanimoto, R. Ohkado, and H. Iida, “Multicomponent Synthesis of Imidazo[1,2-a]Pyridines: Aerobic Oxidative Formation of C–N and C–S Bonds by Flavin–Iodine-Coupled Organocatalysis,” Organic Letters 22, no. 20 (2020): 8002–6. doi:10.1021/acs.orglett.0c02929.
  • I. I. Roslan, K.-H. Ng, J.-E. Wu, G.-K. Chuah, and S. Jaenicke, “Synthesis of Disubstituted 3-Phenylimidazo[1,2-a]Pyridines via a 2-Aminopyridine/CBrCl3 α-Bromination Shuttle,” The Journal of Organic Chemistry 81, no. 19 (2016): 9167–74. doi:10.1021/acs.joc.6b01714.
  • Z. Wu, Y. Pan, and X. Zhou, “Synthesis of 3-Arylimidazo[1,2-a]Pyridines by a Catalyst-Free Cascade Process,” Synthesis 2011, no. 14 (2011): 2255–60. doi:10.1055/s-0030-1260669.
  • F. Vuillermet, J. Bourret, and G. Pelletier, “Synthesis of Imidazo[1,2-a]Pyridines: Triflic Anhydride-Mediated Annulation of 2H-Azirines with 2-Chloropyridines,” The Journal of Organic Chemistry 86, no. 1 (2021): 388–402. doi:10.1021/acs.joc.0c02148.
  • M. Adib, A. Mohamadi, E. Sheikhi, S. Ansari, and H. R. Bijanzadeh, “Microwave-Assisted, One-Pot Reaction of Pyridines, α-Bromoketones and Ammonium Acetate: An Efficient and Simple Synthesis of Imidazo[1,2-a]-Pyridines,” Synlett 2010, no. 11 (2010): 1606–8. doi:10.1055/s-0029-1219962.
  • H. Cao, X. Liu, L. Zhao, J. Cen, J. Lin, Q. Zhu, and M. Fu, “One-Pot Regiospecific Synthesis of Imidazo[1,2-a]pyridines: A Novel, Metal-Free, Three-Component Reaction for the Formation of C-N, C-O, and C-S bonds,” Organic Letters 16, no. 1 (2014): 146–9. doi:10.1021/ol4031414.
  • K. C. Chunavala, G. Joshi, E. Suresh, and S. Adimurthy, “Thermal and Microwave Assisted Rapid Syntheses of Substituted Imidazo[1,2-a]Pyridines under Solvent- and Catalyst-Free Conditions,” Synthesis 2011, no. 04 (2011): 635–41. doi:10.1055/s-0030-1258405.
  • M. Nagaraj, M. Boominathan, S. Muthusubramanian, and N. Bhuvanesh, “Microwave-Assisted Metal-Free Synthesis of 2,8-Diaryl-6-Aminoimidazo-[1,2-a]Pyridine via Amine-Triggered Benzannulation,” Synlett 23, no. 09 (2012): 1353–7. doi:10.1055/s-0031-1290979.
  • A. Sharma, and H-y Li, “A Regioselective and High-Yielding Method for Formaldehyde Inclusion in the 3CC Groebke-Blackburn-Bienaymé Reaction: One-Step Access to 3-Aminoimidazoazines,” Synlett 2011, no. 10 (2011): 1407–12. doi:10.1055/s-0030-1260568.
  • P. R. Adiyala, G. S. Mani, J. B. Nanubolu, K. C. Shekar, and R. A. Maurya, “Access to Imidazo[1,2-a]Pyridines via Annulation of α-Keto Vinyl Azides and 2-Aminopyridines,” Organic Letters 17, no. 17 (2015): 4308–11. doi:10.1021/acs.orglett.5b02124.
  • P. Paengphua, and S. Chancharunee, “Facile Synthesis of Imidazo[1,2-a]Pyridines Promoted by Room-Temperature Ionic Liquids under Ultrasound Irradiation,” Monatshefte Für Chemie - Chemical Monthly 149, no. 10 (2018): 1835–40. doi:10.1007/s00706-018-2238-3.
  • B. M. Vieira, N. Padilha, N. M. Nascimento, G. Perin, D. Alves, R. F. Schumacher, and E. J. Lenardão, “Ultrasound-Assisted Synthesis of Imidazo[1,2-a]Pyridines and Sequential One-Pot Preparation of 3-Selanyl-Imidazo[1,2-a]Pyridine Derivatives,” Arkivoc 2019, no. 2 (2019): 6–23. doi:10.24820/ark.5550190.p010.972.
  • M. Shaikh, D. Wagare, A. Sonone, and A. Durrani, “Highly Efficient Ultrasound Promoted Synthesis of 2-Phenylquinoxaline in Glycerol- Water,” Current Organic Synthesis 17, no. 6 (2020): 483–7. doi:10.2174/1570179417666200529121602.
  • A. Rahman, and S. B. Jonnalagadda, “Simple and Efficient System for the α-Bromination of a β-Ketoester by Using N-Bromosuccinimide in the Presence of Silica-Supported NaHCO3 as the Heterogeneous Catalyst: An Environmentally Benevolent Approach,” Synthetic Communications. 42, no. 8 (2012): 1091–100. doi:10.1080/00397911.2010.530729.
  • T. J. Mason, and D. Peters, Practical Sonochemistry (New York: Ellis Horwood, 1991).
  • T. J. Mason, “Sonochemistry and the Environment – Providing a “Green” Link between Chemistry, Physics and Engineering,” Ultrasonics Sonochemistry 14, no. 4 (2007): 476–83. doi:10.1016/j.ultsonch.2006.10.008.
  • L. D. Lavis, “Ester Bonds in Prodrugs,” ACS Chemical Biology 3, no. 4 (2008): 203–6. doi:10.1021/cb800065s.
  • J.-M. Yang, and C.-C. Chen, “GEMDOCK: A Generic Evolutionary Method for Molecular Docking,” Proteins 55, no. 2 (2004): 288–304. doi:10.1002/prot.20035.
  • iGEMDOCK – A Graphical Environment for Recognizing Pharmacological Interactions and Virtual Screening, see: http://gemdock.life.nctu.edu.tw/igemdock.php
  • X. Zhao, D. Allison, B. Condon, F. Zhang, T. Gheyi, A. Zhang, S. Ashok, M. Russell, I. MacEwan, Y. Qian, et al., “The 2.5 Å Crystal Structure of the SIRT1 Catalytic Domain Bound to Nicotinamide Adenine Dinucleotide (NAD+) and an Indole (EX527 Analogue) Reveals a Novel Mechanism of Histone Deacetylase Inhibition,” Journal of Medicinal Chemistry 56, no. 3 (2013): 963–9. doi:10.1021/jm301431y.
  • Y. Chen, L. L. Fu, X. Wen, X. Y. Wang, J. Liu, Y. Cheng, and J. Huang, “Sirtuin-3 (SIRT3), a Therapeutic Target with Oncogenic and Tumor-Suppressive Function in Cancer,” Cell Death & Disease 5 (2014): e1047. doi:10.1038/cddis.2014.14.
  • T. Y. Alhazzazi, P. Kamarajan, Y. Xu, T. Ai, L. Chen, E. Verdin, and Y. L. Kapila, “A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells,” Anticancer Research 36, no. 1 (2016): 49–60.
  • J. Milne, P. D. Lambert, S. Schenk, D. P. Carney, J. J. Smith, D. J. Gagne, L. Jin, O. Boss, R. B. Perni, C. B. Vu, et al., “Small Molecule Activators of SIRT1 as Therapeutics for the Treatment of Type 2 diabetes,” Nature 450, no. 7170 (2007): 712–6. doi:10.1038/nature06261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.